Ruthenium(III) acetylacetonate, 99.0%, 25g

2-Methyl[1,3]oxazolo[4,5-b]pyridine, 97.0%, 5g

3,9-Bis(octadecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane, 98% Carbon 64.8-69.5 %, 500g

Brucelles pointe courbée, 105 mm 1 pièce

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((diphenyl(p-tolyl)methyl)thio)propanoic acid, 98%, 500mg

N-(5-Methyl-1H-pyrazol-3-yl)acetamide, 95.0%, 5g

HYDRAZINECARBOXYLIC ACID, 2-CYCLOHEXYLIDENE-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 1g

5-Iodoisoquinoline, 95.0%, 10g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine (1:2), 98%, 25g

N-(3-Hydroxyphenyl)acrylamide, 97.0%, 10g

Colonne capillaire GC ROTI®Cap-5 HT, 30 m, 0,32 mm, 0,25 µm, 1 pièce(s)

(2R,3S)-1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid, 98%, 100mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-aminobutyric Acid>98.0%(HPLC)(T)25g